Vysarn Limited
Vysarn Limited (VYS.AX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Vysarn Limited (VYS.AX), featuring income statements, balance sheets, and cash flow data.
Vysarn Limited (VYS.AX) Income Statement & Financial Overview
Analyze Vysarn Limited’s VYS.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $37.002M | $38.88M | $35.87M | $29.08M |
| Cost of Revenue | $36.49M | $30.72M | $32.84M | $25.86M |
| Gross Profit | $509770.00 | $8.16M | $3.03M | $3.23M |
| Gross Profit Ratio | $0.01 | $0.21 | $0.08 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.88M | $2.04M | $1.37M | $1.49M |
| Operating Expenses | $1.88M | $2.04M | $1.37M | $1.49M |
| Total Costs & Expenses | $38.38M | $32.76M | $34.22M | $27.34M |
| Interest Income | $0.00 | $0.00 | $216880.00 | $212694.00 |
| Interest Expense | $196636.00 | $271048.00 | $288552.00 | $243802.00 |
| Depreciation & Amortization | $2.50M | $2.30M | $2.48M | $2.40M |
| EBITDA | $1.55M | $8.57M | $4.19M | $4.24M |
| EBITDA Ratio | $0.04 | $0.22 | $0.12 | $0.14 |
| Operating Income | -$1.37M | $6.12M | $1.66M | $1.74M |
| Operating Income Ratio | -$0.04 | $0.16 | $0.05 | $0.06 |
| Other Income/Expenses (Net) | $6.43M | -$116109.00 | $3.82M | -$141836.00 |
| Income Before Tax | $5.05M | $6.008M | $5.48M | $1.60M |
| Income Before Tax Ratio | $0.14 | $0.15 | $0.15 | $0.05 |
| Income Tax Expense | $1.19M | $1.91M | $1.55M | $1.65M |
| Net Income | $3.86M | $4.10M | $3.93M | -$55275.00 |
| Net Income Ratio | $0.10 | $0.11 | $0.11 | -$0.002 |
| EPS | $0.009 | $0.01 | $0.010 | -$0.00 |
| Diluted EPS | $0.009 | $0.010 | $0.009 | -$0.00 |
| Weighted Avg Shares Outstanding | $408.62M | $405.29M | $396.000M | $395.29M |
| Weighted Avg Shares Outstanding (Diluted) | $419.86M | $422.64M | $412.42M | $395.29M |
The company's financials show resilient growth, with revenue advancing from $29.08M in Q2 2023 to $37.002M in Q4 2024. Gross profit remained healthy with margins at 1% in Q4 2024 compared to 11% in Q2 2023. Operating income hit -$1.37M last quarter, sustaining a consistent -4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.55M. Net income dropped to $3.86M, while earnings per share reached $0.009. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan